A retrospective literature review was conducted to observe trends in responses and overall impact of COVID-19. In response to findings, landscape analyses were conducted on oncology-focused pharmaceutical and biotech companies to quantify the response to the pandemic.

Evaluating the impact of COVID-19 on patients, providers, and the downstream effect on pharmaceutical industry

The DIA Medical Information and Communications Conference is designed by medical information professionals for medical information professionals, building on a long series of very successful past editions. In this conference, we will leverage learnings on how to improve customers' experience as they engage with pharma/biotech companies via various touchpoints. We will also explore when and how to successfully partner with suppliers.

Join medical information professionals and other experts in the field across many sessions, filled with workshops and interactive discussions that will benefit greatly from your active involvement. Together, you will explore how evolving business, regulatory and legal requirements impact daily practice in this line of work. You will gain insights on how novel technologies impact facilitate  information delivery and customer interactions; and how various automation, digital developments and real world evidence may be used enhance in communicating with customers while respecting all relevant guidelines.

Medical Information and Communications Conference

A global, member-driven non-profit organization mobilizing life sciences and healthcare. DIA fosters innovation to improve health and well-being worldwide. Professionals from 80 countries continue to engage with DIA through our unparalleled membership network, educational offerings, and professional development opportunities.